The Use of Oral Hypoglycemic Agents during Pregnancy: An Alternative to Insulin?

CONCLUSION: No significant differences were found in maternal outcomes such as C-section, induction of labor, episiotomy or preterm labor, or neonatal outcomes such as macrosomia, neonatal hypoglycemia or congenital abnormalities among treatment groups. OHA can be considered as an alternative to insulin for the treatment of DM during pregnancy in selected cases.PMID:35077074

Source: Puerto Rico Health Sciences Journal - January 25, 2022 Category: International Medicine & Public Health Authors: Sheila Mercado-M éndez Lorena Gonz ález-Sepúlveda Josefina Romaguera Loida A Gonz ález-Rodríguez Source Type: research